Evidence map›Paper›PMID 21931179›Full record

ReviewAging2011

Epidermal growth factor and aging: a signaling molecule reveals a new eye opening function.

Christopher Rongo

Open access · hybridAbstract readReview
In one paragraph

Review in Aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mechanisms of skin aging induced by EGFR inhibitors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Christopher RongoThe Waksman Institute, Department of Genetics, Rutgers The State University of New Jersey, Piscataway, New Jersey, USA. rongo@waksman.rutgers.edu
Rutgers, The State University of New Jersey · US

Funding

Synapse Formation in the C. elegans Nervous SystemR01NS042023 · NINDS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI RONGO, CHRISTOPHER G · 2002 to 2018
$4.6M
NINDS NIH HHS R01 NS042023NINDS NIH HHS R01 NS42023
6 · The paper itself

Abstract

Epidermal Growth Factor (EGF) is known for its role in promoting cell division and cellular differentiation in developing animals, but we know surprising little about what EGF does in vivo in mature adult animals. Here I review EGF signaling, emphasizing several recent studies that uncovered an unexpected role for EGF in promoting longevity and healthspan in mature adult C. elegans. EGF, acting through phospholipase Cγ and the IP3 receptor signaling, maintains pharyngeal and body wall muscle function in aging adults, and delays the accumulation of lipofuscin-enriched aging pigments within intestinal cells. EGF also acts through the Ras/ERK pathway to regulate protein homeostasis by promoting the expression of antioxidant genes, stimulating the activity of the Ubiquitin Proteasome System (UPS), and repressing the expression of small heat shock protein chaperones. The effects of EGF signaling on lifespan are largely independent of Insulin/IGF-like Signaling (IIS), as the effects of EGF signaling mutants on lifespan and heathspan are not affected by mutations in the DAF-2 insulin receptor or the DAF-16 FOXO transcription factor. Nevertheless, these two signal pathways have multiple points of overlap, coordination, and cross regulation. I propose that the IIS and EGF signaling pathways respond to environment and to developmental timing, respectively, so as to coordinate the appropriate physiological strategy that cells use to maintain protein homeostasis.

Indexed as

AgingAnimalsEpidermal Growth FactorHomeostasisHumansInsulinInsulin-Like Growth Factor ILongevityProteasome Endopeptidase ComplexSignal TransductionUbiquitinEpidermal Growth FactorInsulinInsulin-Like Growth Factor IProteasome Endopeptidase ComplexUbiquitin

Identifiers

PMID21931179
PMCPMC3227454
OpenAlexW2334172337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.